Clinical trial

Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar…

NCT00194129 · University Hospitals Cleveland Medical Center, Other · Completed

Key facts

NCT number NCT00194129
Title Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder
Official title A Randomized, Double Blind Comparison of Lithium Monotherapy Versus Lithium Plus Divalproex for the Outpatient Management of Hypomania/Mania in Patients With Rapid Cycling Bipolar Disorder Comorbid With Substance Abuse/Dependence
Lead sponsor University Hospitals Cleveland Medical Center, Other
Collaborators National Institute of Mental Health (NIMH) NIH Abbott Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Bipolar Disorder
Intervention type Drug
Interventions Lithium, Divalproex, Placebo
Enrollment 31
Start date Nov 1, 1997
Primary completion Sep 1, 2006
Completion Sep 1, 2006
First posted Sep 19, 2005
Last update posted Feb 20, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies